发明名称 BILAYERED COMPOSITE TABLET FORMULATION COMPRISING ATORVASTATIN, IRBESARTAN AND MAGNESIUM CARBONATE
摘要 Disclosed are a bilayered composite tablet formation comprising (a) a first layer comprising irbesartan or a pharmaceutically acceptable salt thereof; and (b) a second layer comprising atorvastatin or a pharmaceutically acceptable salt thereof and magnesium carbonate (MgCO3) in a weight ratio of 1:4 to 1:5, and a method for preparing the same. Exhibiting excellent dissolution rates and bioavailability, the bilayered composite tablet formulation is useful as a therapeutic for hypertension and hypercholesterolemia.
申请公布号 US2015209290(A1) 申请公布日期 2015.07.30
申请号 US201314421467 申请日期 2013.08.30
申请人 HANMI PHARM. CO., LTD 发明人 Kim Yong Il;Cho Jung Hyun;Choi Jun Young;Choi Young Keun;Park Jae Hyun;Woo Jong Soo
分类号 A61K9/20;A61K31/40;A61K9/24;A61K31/4184 主分类号 A61K9/20
代理机构 代理人
主权项 1. A bilayered composite tablet formulation, comprising: (a) a first layer comprising irbesartan or a pharmaceutically acceptable salt thereof; and (b) a second layer comprising atorvastatin or a pharmaceutically acceptable salt thereof and magnesium carbonate in a weight ratio of 1:4 to 1:5.
地址 Hwaseong-si, Gyeonggi-do KR